DA Davidson Weighs in on Prestige Consumer Healthcare Inc.’s Q3 2023 Earnings (NYSE:PBH)

Prestige Consumer Healthcare Inc. (NYSE:PBHGet Rating) – Research analysts at DA Davidson issued their Q3 2023 EPS estimates for shares of Prestige Consumer Healthcare in a research note issued on Monday, November 7th. DA Davidson analyst L. Weiser anticipates that the company will earn $1.01 per share for the quarter. DA Davidson currently has a “Neutral” rating on the stock. The consensus estimate for Prestige Consumer Healthcare’s current full-year earnings is $4.20 per share.

Several other equities research analysts also recently weighed in on PBH. Oppenheimer cut their target price on shares of Prestige Consumer Healthcare to $63.00 in a research note on Thursday, September 29th. StockNews.com started coverage on shares of Prestige Consumer Healthcare in a research note on Wednesday, October 12th. They set a “buy” rating on the stock.

Prestige Consumer Healthcare Price Performance

Shares of PBH opened at $56.80 on Tuesday. Prestige Consumer Healthcare has a fifty-two week low of $48.51 and a fifty-two week high of $63.78. The firm’s 50 day moving average price is $51.87 and its 200 day moving average price is $54.95. The company has a market cap of $2.81 billion, a P/E ratio of 13.79, a PEG ratio of 1.65 and a beta of 0.55. The company has a quick ratio of 1.29, a current ratio of 2.21 and a debt-to-equity ratio of 0.89.

Institutional Investors Weigh In On Prestige Consumer Healthcare

A number of large investors have recently modified their holdings of the company. BlackRock Inc. increased its position in shares of Prestige Consumer Healthcare by 12.4% in the 1st quarter. BlackRock Inc. now owns 9,115,718 shares of the company’s stock valued at $482,584,000 after purchasing an additional 1,004,337 shares during the last quarter. Vanguard Group Inc. increased its position in shares of Prestige Consumer Healthcare by 1.1% in the 1st quarter. Vanguard Group Inc. now owns 5,559,553 shares of the company’s stock valued at $294,322,000 after purchasing an additional 59,740 shares during the last quarter. Dimensional Fund Advisors LP increased its position in shares of Prestige Consumer Healthcare by 0.4% in the 1st quarter. Dimensional Fund Advisors LP now owns 3,448,246 shares of the company’s stock valued at $182,552,000 after purchasing an additional 12,790 shares during the last quarter. State Street Corp increased its position in shares of Prestige Consumer Healthcare by 4.9% in the 2nd quarter. State Street Corp now owns 1,921,456 shares of the company’s stock valued at $112,982,000 after purchasing an additional 89,131 shares during the last quarter. Finally, Macquarie Group Ltd. increased its position in shares of Prestige Consumer Healthcare by 4.4% in the 2nd quarter. Macquarie Group Ltd. now owns 1,887,479 shares of the company’s stock valued at $110,984,000 after purchasing an additional 79,519 shares during the last quarter. 99.37% of the stock is owned by hedge funds and other institutional investors.

About Prestige Consumer Healthcare

(Get Rating)

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.

Further Reading

Earnings History and Estimates for Prestige Consumer Healthcare (NYSE:PBH)

Receive News & Ratings for Prestige Consumer Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Prestige Consumer Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.